Global Minimally Invasive Surgical (MIS) Device Market Size By Type (Product Type I, Product Type II), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Minimally Invasive Surgical (MIS) Device Market was valued at USD 29.6 billion in 2023 and is projected to reach USD 61.8 billion by 2031, growing at a CAGR of 9.5% during the forecast period from 2023 to 2031. The market growth is primarily driven by the increasing prevalence of chronic diseases, technological advancements in surgical equipment, and rising demand for shorter hospital stays and faster recovery times. MIS devices are revolutionizing healthcare by offering procedures with reduced risk, minimal scarring, and faster patient outcomes, making them a preferred choice in both developed and developing healthcare systems.

Drivers

1. Rising Incidence of Chronic Disorders:

The growing global burden of diseases such as cardiovascular conditions, cancer, and gastrointestinal disorders is propelling the demand for MIS procedures, which are less invasive and result in quicker recovery.

2. Technological Advancements:

Innovations in robotic-assisted surgeries, endoscopic systems, and imaging technologies are enhancing the precision and outcomes of MIS, fueling their adoption across a wide range of specialties.

3. Surge in Geriatric Population:

An aging global population, more prone to chronic ailments requiring surgical interventions, is increasing the need for safer, less traumatic surgical solutions such as MIS.

Restraints

1. High Cost of Equipment and Procedures:

The initial investment required for advanced MIS devices and supporting infrastructure remains a barrier, especially in low- and middle-income countries.

2. Limited Access in Rural Areas:

Despite growing awareness, the availability of MIS technology is still limited in remote regions, hindering widespread adoption.

Opportunity

1. Expansion in Emerging Economies:

Rapid improvements in healthcare infrastructure in countries like India, Brazil, and Indonesia are creating new opportunities for MIS device manufacturers.

2. Rising Popularity of Outpatient Surgeries:

The trend toward ambulatory surgical centers and day-care surgeries is significantly boosting demand for minimally invasive tools that support efficient workflows.

Market by System Type Insights

By system type, laparoscopic devices held the largest market share in 2023, driven by their broad applicability in abdominal surgeries and the rising number of gynecological and gastrointestinal procedures. The robotic-assisted surgical systems segment is expected to register the fastest CAGR during the forecast period due to their increasing deployment in complex procedures like prostatectomies and hysterectomies, offering unmatched precision and reduced complications.

Market by End-use Insights

In 2023, hospitals and specialty clinics dominated the MIS device market, accounting for over 60% of global revenue. The segment’s leadership is attributed to the availability of advanced infrastructure, skilled personnel, and a high volume of surgeries. However, ambulatory surgical centers are projected to experience rapid growth owing to their cost-efficiency and shorter patient turnaround times.

Market by Regional Insights

North America led the global MIS device market in 2023 due to well-established healthcare infrastructure, high adoption of cutting-edge technologies, and the presence of key industry players. The Asia-Pacific region is anticipated to witness the fastest growth during the forecast period, driven by increased healthcare investments, expanding medical tourism, and rising awareness of MIS benefits in populous countries like China and India.

Competitive Scenario

Key players in the Global MIS Device Market include Medtronic plc, Johnson & Johnson, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Zimmer Biomet, Intuitive Surgical Inc., Smith & Nephew plc, Karl Storz SE & Co. KG, and CONMED Corporation. These companies are focusing on portfolio expansion through strategic acquisitions, R&D investments, and technological innovation.

Key Market Developments:

2023: Medtronic launched a next-generation laparoscopic visualization platform integrating AI for real-time tissue differentiation.

2024: Johnson & Johnson announced FDA approval for its robotic surgery system "Ottava", expanding its footprint in the robotic MIS landscape.

2025: Intuitive Surgical entered into a strategic collaboration with a major healthcare provider in Asia to enhance access to da Vinci robotic systems.

Scope of Work – Global Minimally Invasive Surgical (MIS) Device Market

Report Metric Details

Market Size (2023) USD 29.6 billion

Projected Market Size (2031) USD 61.8 billion

CAGR (2023–2031) 9.5%

Market Segments By System Type (Laparoscopic, Endoscopic, Robotic, etc.), By End-use (Hospitals, ASCs, Clinics), By Region

Growth Drivers Rise in chronic diseases, technological innovations, aging population

Opportunities Emerging markets expansion, rise of outpatient surgeries

FAQs

1. What is the current market size of the Global Minimally Invasive Surgical (MIS) Device Market?

The market was valued at USD 29.6 billion in 2023.

2. What is the major growth driver of the Global Minimally Invasive Surgical (MIS) Device Market?

Key drivers include increasing chronic disease prevalence, aging population, and technological advancements in surgical devices.

3. Which is the largest region during the forecast period in the Global Minimally Invasive Surgical (MIS) Device Market?

North America holds the largest share due to advanced healthcare infrastructure and rapid technology adoption.

4. Which segment accounted for the largest market share in Global Minimally Invasive Surgical (MIS) Device Market?

Laparoscopic devices dominated the system type segment in 2023.

5. Who are the key market players in the Global Minimally Invasive Surgical (MIS) Device Market?

Major players include Medtronic, Johnson & Johnson, Intuitive Surgical, Olympus, and Stryker.